Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. agreed to acquire 9% of stake in Charmacy Pharmaceutical Co., Ltd. (SEHK:2289) from Yao Chuanglong for HKD 70.9 million on September 13, 2022. The transaction is subject to approval of state-owned assets supervisory authority and SAMR. Guotai Junan Capital acted as financial advisor to Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 HKD | -0.14% | -0.72% | +7.10% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.10% | 192M | |
-34.16% | 14.83B | |
-24.55% | 12.04B | |
-25.24% | 6.52B | |
+14.96% | 6.44B | |
-8.01% | 6.15B | |
-2.34% | 4.64B | |
+60.00% | 4.62B | |
-8.10% | 3.93B | |
-11.16% | 3.49B |
- Stock Market
- Equities
- 2289 Stock
- News Charmacy Pharmaceutical Co., Ltd.
- Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. agreed to acquire 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong for HKD 70.9 million.